$CORT
Corcept Therapeutics Inc

2018 Q1 Form 10-Q Financial Statement

#000156459018011954 Filed on May 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $57.66M $27.60M
YoY Change 108.92% 71.84%
Cost Of Revenue $1.174M $646.0K
YoY Change 81.73% 60.3%
Gross Profit $56.49M $26.95M
YoY Change 109.57% 72.14%
Gross Profit Margin 97.96% 97.66%
Selling, General & Admin $18.44M $15.04M
YoY Change 22.63% 44.14%
% of Gross Profit 32.65% 55.79%
Research & Development $17.05M $7.176M
YoY Change 137.6% 54.86%
% of Gross Profit 30.19% 26.62%
Depreciation & Amortization $48.00K $13.00K
YoY Change 269.23% -51.85%
% of Gross Profit 0.08% 0.05%
Operating Expenses $35.49M $22.21M
YoY Change 59.77% 47.44%
Operating Profit $21.00M $4.740M
YoY Change 342.93% 700.68%
Interest Expense $290.0K -$270.0K
YoY Change -207.41% -53.45%
% of Operating Profit 1.38% -5.7%
Other Income/Expense, Net $50.00K
YoY Change -266.67%
Pretax Income $21.29M $4.515M
YoY Change 371.52% -23863.16%
Income Tax $3.830M $127.0K
% Of Pretax Income 17.99% 2.81%
Net Earnings $17.46M $4.388M
YoY Change 297.88% -23194.74%
Net Earnings / Revenue 30.28% 15.9%
Basic Earnings Per Share $0.15 $0.04
Diluted Earnings Per Share $0.14 $0.04
COMMON SHARES
Basic Shares Outstanding 114.9M shares 112.9M
Diluted Shares Outstanding 127.7M shares 121.2M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.4M $52.80M
YoY Change 137.5% 29.73%
Cash & Equivalents $33.12M $38.00M
Short-Term Investments $92.20M $14.80M
Other Short-Term Assets $3.300M $1.800M
YoY Change 83.33% 63.64%
Inventory $4.900M $2.900M
Prepaid Expenses
Receivables $17.30M $9.200M
Other Receivables $0.00 $0.00
Total Short-Term Assets $150.8M $66.70M
YoY Change 126.09% 32.08%
LONG-TERM ASSETS
Property, Plant & Equipment $600.0K $300.0K
YoY Change 100.0% 200.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $15.00M $4.500M
YoY Change 233.33%
Other Assets $76.60M $3.900M
YoY Change 1864.1% 69.57%
Total Long-Term Assets $92.20M $8.639M
YoY Change 967.25% 259.96%
TOTAL ASSETS
Total Short-Term Assets $150.8M $66.70M
Total Long-Term Assets $92.20M $8.639M
Total Assets $243.0M $75.34M
YoY Change 222.54% 42.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.900M $4.253M
YoY Change 85.75% 102.52%
Accrued Expenses $19.20M $9.938M
YoY Change 93.2% 77.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $10.11M
YoY Change -37.99%
Total Short-Term Liabilities $27.70M $25.80M
YoY Change 7.36% 7.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.70M $25.80M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $27.70M $25.80M
YoY Change 7.36% -21.1%
SHAREHOLDERS EQUITY
Retained Earnings -$317.9M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $215.2M $49.58M
YoY Change
Total Liabilities & Shareholders Equity $243.0M $75.34M
YoY Change 222.54% 42.42%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $17.46M $4.388M
YoY Change 297.88% -23194.74%
Depreciation, Depletion And Amortization $48.00K $13.00K
YoY Change 269.23% -51.85%
Cash From Operating Activities $34.43M $9.600M
YoY Change 258.65% 190.91%
INVESTING ACTIVITIES
Capital Expenditures $77.00K $110.0K
YoY Change -30.0% 400.0%
Acquisitions
YoY Change
Other Investing Activities -$34.20M -$19.30M
YoY Change 77.2%
Cash From Investing Activities -$34.29M -$19.40M
YoY Change 76.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $0.00 $4.832M
YoY Change -100.0% 58.9%
Cash From Financing Activities $1.922M -3.700M
YoY Change -151.95% 23.33%
NET CHANGE
Cash From Operating Activities $34.43M 9.600M
Cash From Investing Activities -$34.29M -19.40M
Cash From Financing Activities $1.922M -3.700M
Net Change In Cash $2.059M -13.50M
YoY Change -115.25% -4600.0%
FREE CASH FLOW
Cash From Operating Activities $34.43M $9.600M
Capital Expenditures $77.00K $110.0K
Free Cash Flow $34.35M $9.490M
YoY Change 261.99% 189.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114882000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112867000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127733000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121189000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
48000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4954000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
21289000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4515000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3830000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
127000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
17459000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
4388000
CY2017Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-54000
CY2018Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
57659000
CY2018Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1174000
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
646000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17050000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7176000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18440000
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15037000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
36664000
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
22859000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20995000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4740000
CY2018Q1 cort Interest And Other Income Expense
InterestAndOtherIncomeExpense
294000
CY2017Q1 cort Interest And Other Income Expense
InterestAndOtherIncomeExpense
-225000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-152000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17307000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4376000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3169000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2701000
CY2017Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2018Q1 cort Accretion Of Interest Income Expense
AccretionOfInterestIncomeExpense
-198000
CY2017Q1 cort Accretion Of Interest Income Expense
AccretionOfInterestIncomeExpense
270000
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48000
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1961000
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-646000
CY2018Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-12876000
CY2017Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-590000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
635000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
23000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-759000
CY2018Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1239000
CY2018Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2383000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
34430000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
9561000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
77000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
110000
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
16650000
CY2017Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2018Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
50866000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-34293000
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1922000
CY2018Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1922000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2059000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51536000
CY2018Q1 cort Product Revenue Allowance And Reserve Provision Related To Prior Period Sales
ProductRevenueAllowanceAndReserveProvisionRelatedToPriorPeriodSales
75000
CY2018Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1998-05-01
CY2018Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2017Q4 cort Product Revenue Allowances And Reserves Balance
ProductRevenueAllowancesAndReservesBalance
8888000
CY2018Q1 cort Product Revenue Allowance And Reserve Provision Related To Current Period Sales
ProductRevenueAllowanceAndReserveProvisionRelatedToCurrentPeriodSales
8139000
CY2018Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q1 us-gaap Accretion Expense
AccretionExpense
0
CY2017Q1 us-gaap Accretion Expense
AccretionExpense
300000
CY2018Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
100000
CY2018Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
0
CY2017Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
0
CY2018Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2019-03-31
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2017Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1030000
CY2018Q1 cort Product Revenue Allowance And Reserve Credit Or Payments Made During Period
ProductRevenueAllowanceAndReserveCreditOrPaymentsMadeDuringPeriod
-6566000
CY2018Q1 cort Product Revenue Allowances And Reserves Balance
ProductRevenueAllowancesAndReservesBalance
10536000
CY2018Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q1 cort Number Of Customer Groups
NumberOfCustomerGroups
2
CY2018Q1 cort Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
3465000
CY2017Q4 cort Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
4287000
CY2018Q1 cort Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
14000
CY2017Q4 cort Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
64000
CY2018Q1 cort Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
4307000
CY2017Q4 cort Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
4025000
CY2018Q1 cort Inventory Current Noncurrent
InventoryCurrentNoncurrent
7786000
CY2017Q4 cort Inventory Current Noncurrent
InventoryCurrentNoncurrent
8376000
CY2018Q1 cort Accrued Government Rebate Current
AccruedGovernmentRebateCurrent
10020000
CY2017Q4 cort Accrued Government Rebate Current
AccruedGovernmentRebateCurrent
7961000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4039000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8574000
CY2018Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
728000
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
66000
CY2018Q1 cort Accrued Legal Fees Current
AccruedLegalFeesCurrent
400000
CY2017Q4 cort Accrued Legal Fees Current
AccruedLegalFeesCurrent
276000
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
313000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
207000
CY2018Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
240000
CY2017Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
208000
CY2018Q1 cort Accrued Manufacturing Costs
AccruedManufacturingCosts
57000
CY2017Q4 cort Accrued Manufacturing Costs
AccruedManufacturingCosts
955000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
616000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
496000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-100000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2018Q1 cort Marketable Securities Maximum Maturity Period
MarketableSecuritiesMaximumMaturityPeriod
P2Y
CY2018Q1 cort Marketable Securities Weighted Average Maturity Period
MarketableSecuritiesWeightedAverageMaturityPeriod
P6M
CY2018Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
340000
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2018Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1370000
CY2018Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q1 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
0
CY2018Q1 cort Number Of Stock Option Plans
NumberOfStockOptionPlans
2
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
479000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4954000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2701000
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12851000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8322000
CY2018Q1 cort Earnings Per Share Potentially Dilutive Securities Stock Options Outstanding
EarningsPerSharePotentiallyDilutiveSecuritiesStockOptionsOutstanding
23117000
CY2017Q1 cort Earnings Per Share Potentially Dilutive Securities Stock Options Outstanding
EarningsPerSharePotentiallyDilutiveSecuritiesStockOptionsOutstanding
20880000
CY2018Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
1300000
CY2018Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3200000
CY2018Q1 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
600000
CY2018Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21

Files In Submission

Name View Source Status
0001564590-18-011954-index-headers.html Edgar Link pending
0001564590-18-011954-index.html Edgar Link pending
0001564590-18-011954.txt Edgar Link pending
0001564590-18-011954-xbrl.zip Edgar Link pending
cort-10q_20180331.htm Edgar Link pending
cort-20180331.xml Edgar Link completed
cort-20180331.xsd Edgar Link pending
cort-20180331_cal.xml Edgar Link unprocessable
cort-20180331_def.xml Edgar Link unprocessable
cort-20180331_lab.xml Edgar Link unprocessable
cort-20180331_pre.xml Edgar Link unprocessable
cort-ex311_10.htm Edgar Link pending
cort-ex312_8.htm Edgar Link pending
cort-ex321_9.htm Edgar Link pending
cort-ex322_11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending